240 related articles for article (PubMed ID: 16426447)
1. Microsatellite instability analysis in hereditary non-polyposis colon cancer using the Bethesda consensus panel of microsatellite markers in the absence of proband normal tissue.
Chialina SG; Fornes C; Landi C; de la Vega Elena CD; Nicolorich MV; Dourisboure RJ; Solano A; Solis EA
BMC Med Genet; 2006 Jan; 7():5. PubMed ID: 16426447
[TBL] [Abstract][Full Text] [Related]
2. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
[TBL] [Abstract][Full Text] [Related]
3. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
[TBL] [Abstract][Full Text] [Related]
4. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer.
Frazier ML; Sinicrope FA; Amos CI; Cleary KR; Lynch PM; Levin B; Luthra R
Oncol Rep; 1999; 6(3):497-505. PubMed ID: 10203581
[TBL] [Abstract][Full Text] [Related]
5. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
[TBL] [Abstract][Full Text] [Related]
6. A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy.
Bianchi F; Galizia E; Porfiri E; Belvederesi L; Catalani R; Loretelli C; Bracci R; Bearzi I; Turchi C; Viel A; Cellerino R
Fam Cancer; 2007; 6(1):97-102. PubMed ID: 17165155
[TBL] [Abstract][Full Text] [Related]
7. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
[TBL] [Abstract][Full Text] [Related]
8. The novel germline mutation of hMSH2 gene in a case of a hereditary non-polyposis colorectal cancer (HNPCC) patient who meets the revised Amsterdam criteria.
Tomita N; Fukunaga M; Ohzato H; Tamura S; Sugimoto K; Aihara T; Miki H; Takatsuka Y; Matsuura N; Iwanaga T; Fukayama N; Sugano K
Jpn J Clin Oncol; 2003 Sep; 33(9):486-9. PubMed ID: 14594944
[TBL] [Abstract][Full Text] [Related]
9. [A new oncogenetic service of counseling and diagnosing for hereditary non-polyposis colorectal cancer (HNPCC)].
Goldberg Y; Porat R; Sagi M; Eilat A; Kedar I; Shochat C; Mendelson S; Hamburger T; Nissan A; Hubert A; Shalev S; Bercovich D; Pikarski E; Lerer I; Abeliovich D; Pretetz T
Harefuah; 2007 Jul; 146(7):510-4, 576, 575. PubMed ID: 17803162
[TBL] [Abstract][Full Text] [Related]
10. [Fenotypical diversity of hereditary non-polyposis colorectal carcinoma. Pedigree and genetical analysis of two mutation carrier patients].
Tanyi M; Kanyári Z; Juhász B; Lukács G; Olasz J; Kámory E; Csuka O; Tóth L; Damjanovich L
Magy Seb; 2006 Dec; 59(6):411-20. PubMed ID: 17432081
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer.
Lamberti C; Kruse R; Ruelfs C; Caspari R; Wang Y; Jungck M; Mathiak M; Malayeri HR; Friedl W; Sauerbruch T; Propping P
Gut; 1999 Jun; 44(6):839-43. PubMed ID: 10323887
[TBL] [Abstract][Full Text] [Related]
12. The novel germline mutation of the hMLH1 gene in a case of suspected hereditary non-polyposis colorectal cancer (HNPCC) in a patient with no family history of cancer.
Tomita N; Fukunaga M; Okamura S; Nakata K; Ohzato H; Tamura S; Sugimoto K; Aihara T; Miki H; Takatsuka Y; Matsuura N; Ishikawa H; Iwanaga T; Fukayama N; Sugano K
Jpn J Clin Oncol; 2004 Sep; 34(9):556-60. PubMed ID: 15466831
[TBL] [Abstract][Full Text] [Related]
13. [Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology?].
Rüschoff J; Dietmaier W; Bocker T; Wallinger S; Kullmann F; Beham A; Hofstädter F
Pathologe; 1998 Jul; 19(4):269-78. PubMed ID: 9746911
[TBL] [Abstract][Full Text] [Related]
14. Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer.
Huang SC; Lavine JE; Boland PS; Newbury RO; Kolodner R; Pham TT; Arnold CN; Boland CR; Carethers JM
J Pediatr; 2001 May; 138(5):629-35. PubMed ID: 11343035
[TBL] [Abstract][Full Text] [Related]
15. A novel germline mutation of hMLH1 in a Korean hereditary non-polyposis colorectal cancer family.
Kim KH; Kim JY; Oh SI; Baik HW; Kang DW; Jung SH; Rho JH; Hwang IT
Int J Oncol; 2009 May; 34(5):1313-8. PubMed ID: 19360343
[TBL] [Abstract][Full Text] [Related]
16. Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer.
Tanyi M; Olasz J; Lukács G; Csuka O; Tóth L; Szentirmay Z; Ress Z; Barta Z; Tanyi JL; Damjanovich L
World J Gastroenterol; 2006 Feb; 12(8):1192-7. PubMed ID: 16534870
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum.
Soravia C; van der Klift H; Bründler MA; Blouin JL; Wijnen J; Hutter P; Fodde R; Delozier-Blanchet C
Am J Med Genet A; 2003 Aug; 121A(2):159-62. PubMed ID: 12910497
[TBL] [Abstract][Full Text] [Related]
18. [Screening the hereditary nonpolyposis colorectal cancer by revised Bethesda guideline: a cohort study of 110 cases].
Jin HY; Ding YJ; Liu XF; Yang BL; Lai RS; Ni M; Ge YS
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1445-7. PubMed ID: 17785078
[TBL] [Abstract][Full Text] [Related]
19. Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation.
Lastella P; Patruno M; Forte G; Montanaro A; Di Gregorio C; Sabbà C; Suppressa P; Piepoli A; Panza A; Andriulli A; Resta N; Stella A
Fam Cancer; 2011 Jun; 10(2):285-95. PubMed ID: 21286823
[TBL] [Abstract][Full Text] [Related]
20. Influence of selection criteria on mutation detection in patients with hereditary nonpolyposis colorectal cancer.
Heinimann K; Scott RJ; Buerstedde JM; Weber W; Siebold K; Attenhofer M; Müller H; Dobbie Z
Cancer; 1999 Jun; 85(12):2512-8. PubMed ID: 10375096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
